Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-05-11

Clinical Trial Update: Clinical Trial of YYC301 for Treatment of Osteoarthritis of the Knee [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for YYC301 in knee osteoarthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • YYC301

Snippet

Sponsor: Yooyoung Pharmaceutical Co., Ltd. | Conditions: Osteoarthritis, Knee | Phase 2 | Status: COMPLETED